LVTX
LAVA Therapeutics
LVTX
LVTX
Delisted
LVTX was delisted on the 20th of November, 2025.
18 hedge funds and large institutions have $95.5M invested in LAVA Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.48M | |
| 2 | +$635K | |
| 3 | +$141K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$15.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$15.6K |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$950K | |
| 3 | -$851K | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$820K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$456K |